A clinical trial to study effect of topical application of Argyreia Speciosa gel and Triphala gel as an adjunct to scaling in gingivitis patients.
- Conditions
- Health Condition 1: K051- Chronic gingivitis
- Registration Number
- CTRI/2023/09/057522
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Chronic gingivitis patients with a minimum of 16 gradable teeth.
2) Systemically healthy patients.
3) Patients requiring scaling.
4) Both males and females between the age group of 20-60 year with = 3 mm of probing depth
(PD).
5) Patient not on systemic antibiotics for the past 3 months.
6) No use of anti-inflammatory drugs within the past 3 months
7) Availability of the patient for the entire duration of the study.
8) Not receiving periodontal treatment within last 6 months.
9) Patient should be able to understand and give a written informed consent
1) Patients with history of deleterious habits (i.e., use of tobacco consumption etc.)
2) Patients with systemic diseases (i.e., diabetes mellitus, cancer, HIV, bone metabolic
diseases).
3) Patients on systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or
chemotherapy prescribed or received within 2 months prior to study entry.
4) Pregnant and/or lactating females.
5) Patients contraindicated for scaling
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in gingival inflammation and plaque formationTimepoint: Baseline to 15 Days
- Secondary Outcome Measures
Name Time Method -Timepoint: -